Dimerix Ltd
ASX:DXB

Watchlist Manager
Dimerix Ltd Logo
Dimerix Ltd
ASX:DXB
Watchlist
Price: 0.505 AUD -0.98% Market Closed
Market Cap: 293.4m AUD

Wall Street
Price Targets

DXB Price Targets Summary
Dimerix Ltd

There are no price targets for DXB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Dimerix Ltd Competitors:
Price Targets
LYEL
Lyell Immunopharma Inc
68% Upside
9688
Zai Lab Ltd
29% Upside
BDTX
Black Diamond Therapeutics Inc
369% Upside
4974
Takara Bio Inc
64% Upside
1801
Innovent Biologics Inc
20% Downside
OPK
OPKO Health Inc
144% Upside
PRTC
PureTech Health PLC
271% Upside
IONS
Ionis Pharmaceuticals Inc
62% Upside

Revenue
Forecast

Revenue Estimate
Dimerix Ltd

For the last 8 years the compound annual growth rate for Dimerix Ltd's revenue is 38%. The projected CAGR for the next 1 year is 4 898%.

38%
Past Growth
4 898%
Estimated Growth
Estimates Accuracy
-99%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Dimerix Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
69%
Average Beat

Net Income
Forecast

Net Income Estimate
Dimerix Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DXB's stock price target?
Not Available

DXB doesn't have any price targets made by Wall Street professionals.

What is Dimerix Ltd's Revenue forecast?
Projected CAGR
4 898%

For the last 8 years the compound annual growth rate for Dimerix Ltd's revenue is 38%. The projected CAGR for the next 1 year is 4 898%.

Back to Top